Evidence map›Paper›PMID 36952018›Full record

ArticleCellular and molecular life sciences : CMLS2023

Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress.

Yuan Hu, Chenyang Qi, Jiaoyu Shi, Weiqiang Tan, Adiljan Abdurusul, Zhonghua Zhao, Yanyong Xu, Huijuan Wu, Zhigang Zhang

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. The Life of a Kidney Podocyte.Acta physiologica (Oxford, England) · 2025
    Review
  3. Article
  4. High-mobility group box 1 in acute kidney injury.Frontiers in pharmacology · 2025
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Yuan Hu *Department of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dong'an Road, Shanghai, 200032, People's Republic of China.
Chenyang Qi *Department of Nephrology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Jiaoyu ShiDepartment of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dong'an Road, Shanghai, 200032, People's Republic of China.
Weiqiang TanDepartment of Surgery, Xiang'an Hospital, School of Medicine, Xiamen University, Xiamen, China.
Adiljan AbdurusulDepartment of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dong'an Road, Shanghai, 200032, People's Republic of China.
Zhonghua ZhaoDepartment of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dong'an Road, Shanghai, 200032, People's Republic of China.
Yanyong XuKey Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Pathology of School of Basic Medical Sciences, Fudan University, Shanghai, China. yanyong_xu@fudan.edu.cn.
Huijuan WuDepartment of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dong'an Road, Shanghai, 200032, People's Republic of China. hjwu@shmu.edu.cn.
Zhigang ZhangDepartment of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dong'an Road, Shanghai, 200032, People's Republic of China. zzg@shmu.edu.cn.ORCID http://orcid.org/0000-0001-7895-9332
Fudan University · CNShanghai Medical College of Fudan University · CNSun Yat-sen University · CNTongji University · CNXiamen University · CN

Funding

National Natural Science Foundation of China 82170719
6 · The paper itself

Abstract

Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) is a unique component of the ubiquitin-proteasome system (UPS), which has multiple activities in maintaining intracellular ubiquitin levels. We previously reported the aberrant low expression of UCHL1 in podocytes of non-immune complex-mediated glomerulonephritis, and recent studies indicate that anti-UCHL1 antibody was responsible for the refractory minimal change disease (MCD), but the specific effect of UCHL1 to the podocytopathy has not been determined. Therefore, we generated podocyte-specific UCHL1 gene knockout (UCHL1

Indexed as

Kidney DiseasesPodocytesAnimalsEndoplasmic Reticulum StressGlomerulosclerosis, Focal SegmentalProteasome Endopeptidase ComplexRatsUbiquitinUbiquitinationUbiquitin ThiolesteraseProteasome Endopeptidase ComplexUbiquitinUbiquitin ThiolesteraseEndoplasmic reticulum stressPodocyte apoptosisPodocytopathyUbiquitin carboxyl-terminal hydrolase L1 (UCHL1)Ubiquitin–proteasome system (UPS)

Identifiers

PMID36952018
PMCPMC11073152
OpenAlexW4360601086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.